Shots:

• The EMA’s CHMP has issued a positive opinion for the COVID-19 vaccine as a booster dose for adults aged ≥18yrs. in patients with COVID-19 for 2mos. after primary shot with a single-shot of the COVID-19 vaccine
• The CHMP recommendation is based on a P-III (ENSEMBLE 2) study of COVID-19 booster vaccine which showed a 75% protection against symptomatic COVID-19 globally @2mos. after primary shot, 94% against symptomatic COVID-19 in the US & 100% against severe COVID-19 @14 days post-booster vaccination, was well-tolerated & no new safety signals were observed
• The results from multiple RWE studies showed similar effectiveness in the single-shot vaccine as observed in randomized clinical trials

Ref: J&J | Image: J&J